Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indexing-based differential display--studies on post-mortem Alzheimer's brains.

M Ryan1, M Starkey, R Faull

  • 1Department of Neurobiology, Babraham Institute, Cambridge CB2 4AT, UK.

Brain Research. Molecular Brain Research
|April 11, 2001
PubMed
Summary

A new gene expression analysis method proved effective for studying Alzheimer's disease (AD) in post-mortem brain tissue. The technique identified significant gene expression changes, including reduced calcineurin and GAP-43, confirming its utility for AD research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why do healthcare professionals fail to escalate as per the early warning system (EWS) protocol? A qualitative evidence synthesis of the barriers and facilitators of escalation.

BMC emergency medicine·2021
Same author

Low failure to attend rates and increased clinic capacity with Telehealth: A highly effective outpatient model that should continue beyond the COVID-19 pandemic.

Journal of gastroenterology and hepatology·2020
Same author

An agenda for research and action toward diverse and just futures for life on Earth.

Conservation biology : the journal of the Society for Conservation Biology·2020
Same author

Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland.

Aging & mental health·2020
Same author

Effect of size and location of simulated lytic lesions on the structural properties of human vertebral bodies, a micro-finite element study.

Bone reports·2020
Same author

COVID-19: vision and fitness to drive.

QJM : monthly journal of the Association of Physicians·2020

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
  • Understanding gene expression changes in the brain is crucial for elucidating AD pathogenesis.
  • Existing methods for analyzing gene expression in post-mortem human tissue have limitations.

Purpose of the Study:

  • To validate a novel indexing-based differential display technique for analyzing gene expression in human post-mortem brain tissue.
  • To identify differentially expressed genes in the prefrontal cortex of individuals with Alzheimer's disease compared to controls.
  • To confirm the reproducibility and validity of the novel technique.

Main Methods:

  • Application of a novel indexing-based differential display technique to human post-mortem prefrontal cortex tissue.

Related Experiment Videos

  • Comparison of gene expression profiles between Alzheimer's disease (AD) and control brain samples.
  • Validation of differential display results using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).

    • Main Results:

    • The novel differential display technique yielded valid and reproducible results.
    • Significant changes in gene expression were observed in AD brains compared to controls.
    • Key genes identified include calcineurin (implicated in tau phosphorylation) and GAP-43 (involved in synapse remodelling), with notable reductions in AD.
    • RT-PCR confirmed these findings in a larger cohort.

    Conclusions:

    • The novel indexing-based differential display is a reliable method for studying gene expression in human post-mortem brain tissue.
    • This technique successfully identified disease-associated gene expression alterations in Alzheimer's disease.
    • The findings highlight the potential of calcineurin and GAP-43 as biomarkers or therapeutic targets in AD.